Table 1.
Baseline Characteristics of Participants*
| Total Enrolled | Completed | Screen Failed | P Value | |
|---|---|---|---|---|
| Number | 38 | 10 | 28 | — |
| Age, yr | 26 ± 7 | 25 ± 5 | 26 ± 8 | 0.90 |
| Female/male, n | 18/20 | 3/7 | 15/13 | 0.28 |
| FEV1, % predicted | 90 ± 16 | 96 ± 19 | 88 ± 15 | 0.21 |
| FEV1/FVC | 0.77 ± 0.07 | 0.78 ± 0.08 | 0.77 ± 0.07 | 0.75 |
| Methacholine PC20, mg/ml† | 1.7 ± 2.8 | 1.5 ± 2.7 | 1.8 ± 2.8 | 0.90 |
Definition of abbreviation: PC20 = provocative concentration of methacholine causing a 20% fall in FEV1.
*
Data are expressed as means ± SD unless indicated otherwise.
†
Geometric mean ± median absolute deviation; n = 13 participants for screen failed.